| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 10/10/2001 | EP1141389A2 Reagents and methods useful for detecting diseases of the breast |
| 10/10/2001 | EP1141376A1 Peptidoglycan recognition proteins |
| 10/10/2001 | EP1141365A1 Method for preparing suspension of stable posiplexes |
| 10/10/2001 | EP1141364A1 Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 10/10/2001 | EP1141362A1 Gene transfer vector for the diagnosis and therapy of malign tumors |
| 10/10/2001 | EP1141361A1 Compositions and methods for packaging of alphavirus vectors |
| 10/10/2001 | EP1141357A1 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
| 10/10/2001 | EP1141343A1 Non-viral transfection vector |
| 10/10/2001 | EP1141342A2 Use of plus-strand synthesis elements in retroviral vectors |
| 10/10/2001 | EP1141340A1 A method for introducing substances into cells, and use of said method |
| 10/10/2001 | EP1141339A1 Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 |
| 10/10/2001 | EP1141338A1 Recombinant herpes simplex virus useful for treating neoplastic disease |
| 10/10/2001 | EP1141334A2 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof |
| 10/10/2001 | EP1141331A2 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE) |
| 10/10/2001 | EP1141326A2 Human akt-3 |
| 10/10/2001 | EP1141325A1 Ikk3 kinase |
| 10/10/2001 | EP1141319A2 Extending graft survival by heme oxygenase-i expression induced immunomodulation |
| 10/10/2001 | EP1141318A2 P450 / acetaminophen gdept for cancer treatment |
| 10/10/2001 | EP1141315A2 Modified hiv env polypeptides |
| 10/10/2001 | EP1141314A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 10/10/2001 | EP1141313A2 Improved expression of hiv polypeptides and production of virus-like particles |
| 10/10/2001 | EP1141305A1 Chimeric gene encoding the antigenic determinants of four proteins of l. infantum |
| 10/10/2001 | EP1141296A2 Interferon-epsilon |
| 10/10/2001 | EP1141290A2 Compositions and methods for therapy and diagnosis of ovarian cancer |
| 10/10/2001 | EP1141279A2 Tissue repair protein involved in orofacial clefting and uses thereof |
| 10/10/2001 | EP1141278A2 Therapeutic phosphodiesterase inhibitors |
| 10/10/2001 | EP1141276A2 Novel polypeptides and nucleic acids encoding same |
| 10/10/2001 | EP1141268A2 $i(A. FUMIGATUS) ACETYL COENZYME-A CARBOXYLASE GENES AND POLYPEPTIDES AND USES THEREOF |
| 10/10/2001 | EP1141266A2 Expression vectors comprising multiple shear stress responsive elements (ssre) and a gene of interest and methods of use thereof |
| 10/10/2001 | EP1141265A1 Double nuclear transfer method and results thereof |
| 10/10/2001 | EP1141247A2 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells |
| 10/10/2001 | EP1141245A1 Somatic cells with ablated prp gene and methods of use |
| 10/10/2001 | EP1141241A2 Astrocytes, their preparation and uses thereof |
| 10/10/2001 | EP1141020A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 10/10/2001 | EP1141017A2 Characterization of the soc/crac calcium channel protein family |
| 10/10/2001 | EP1141013A2 EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS |
| 10/10/2001 | EP1141002A1 Human cervical cancer 1 protooncogene and protein encoded therein |
| 10/10/2001 | EP1140999A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 10/10/2001 | EP1140998A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 10/10/2001 | EP1140997A2 Chlamydia trachomatis antigens |
| 10/10/2001 | EP1140996A2 Type iii secretion system antigens from bordetella pertussis |
| 10/10/2001 | EP1140978A1 Methods of identifying antigen gene sequences |
| 10/10/2001 | EP1140971A1 Antisense modulation of novel anti-apoptotic bcl-2-related proteins |
| 10/10/2001 | EP1140970A1 47 human secreted proteins |
| 10/10/2001 | EP1140969A1 Connective tissue growth factor fragments and methods and uses thereof |
| 10/10/2001 | EP1140967A1 Targeted gene transfer using g protein coupled receptors |
| 10/10/2001 | EP1140966A1 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof |
| 10/10/2001 | EP1140965A1 Protonated/acidified nucleic acids and methods of use |
| 10/10/2001 | EP1140964A2 Connective tissue growth factor fragments and methods and uses thereof |
| 10/10/2001 | EP1140273A2 Device for locally delivering a drug in a body cavity |
| 10/10/2001 | EP1140208A1 Pharmaceutical compositions comprising immortalised endothelial cells |
| 10/10/2001 | EP1140207A1 Mammalian cell preparations optionally transfected with a gene coding for an active substance containing same |
| 10/10/2001 | EP1140206A1 Interferon gamma inducing factor based vaccine and use of same for protective immunity against multiple sclerosis |
| 10/10/2001 | EP1140205A2 GENE THERAPY FOR PULMONARY EDEMA USING ADENOVIRUS VECTORS ENCODING Na,K-ATPase |
| 10/10/2001 | EP1140154A2 Chorionic gonadotropin dna vaccines and methods |
| 10/10/2001 | EP1140141A2 Methods for treating cancer and for mediating chemotaxis of dendritic cells |
| 10/10/2001 | EP1140120A2 Human brainiac-5 |
| 10/10/2001 | EP1140023A2 Integrative protein-dna cochleate formulations and methods for transforming cells |
| 10/10/2001 | EP1140020A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 10/10/2001 | EP1140019A1 Aerosol formulations for buccal and pulmonary application |
| 10/10/2001 | EP1140015A1 Polynucleotide compositions for intramuscular and intradermal administration |
| 10/10/2001 | EP1139751A1 Efficient and stable $i(in vivo) gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors |
| 10/10/2001 | EP1139750A1 Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues |
| 10/10/2001 | CN1317045A Pharmaceutical uses of NAB1 and NAB2 |
| 10/10/2001 | CN1317043A Polypeptides and polynucleotides from coagulase-negative staphylocoui |
| 10/09/2001 | US6300492 Nucleotide sequences for the prevention of suppression of apoptosis and treatment lymphoma, leukemia, melanoma, ovarian, mammary gland, pancreatic and lung cancers |
| 10/09/2001 | US6300491 Antisense nucleotide for the treatment of allograft defects, cancers and metastasis, inflammatory bowel disease, psoriasis and skin disorders |
| 10/09/2001 | US6300490 Expression vector coding cytosine deaminase; for use in the treatment of cancers |
| 10/09/2001 | US6300488 Modified lepidopteran receptors and hybrid multifunctional proteins for use in transcription and regulation of transgene expression |
| 10/09/2001 | US6300484 DNA encoding DP. 75 and a process for its use |
| 10/09/2001 | US6300321 Compounds, preparation and use for transferring nucleic acids into cells |
| 10/09/2001 | US6300318 Antibacterial and antibiotic methods using peptide nucleic acids and pharmaceutical compositions therefor |
| 10/09/2001 | US6300317 Eukarotic cells, polynucleotide, functional agents, membrane permeability, subcellar localization agents and polynucleotide masking agents |
| 10/09/2001 | US6300310 Amino acid sequence with segments of polypeptides |
| 10/09/2001 | US6300127 Bone mineralization proteins, DNA, vectors, expression systems |
| 10/09/2001 | US6300126 Nucleotide sequences for use in diagnosis, treatment of genetic disorders; for use in gene therapy |
| 10/09/2001 | US6300118 Plasmids comprising a genetically altered feline immunodeficiency virus genome |
| 10/09/2001 | US6300097 A polypeptide; therapy and diagnosis of bacterial infections; upper respiratory infections, toxic shock syndrome, septic arthritis and intestinal disorders |
| 10/09/2001 | US6299883 Tarf |
| 10/09/2001 | US6299882 UL54.5 of Marek's disease virus (MDV) |
| 10/09/2001 | US6299880 Cell surface protein compounds |
| 10/09/2001 | US6299876 Cytotoxic drug therapy |
| 10/09/2001 | CA2235025C Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis |
| 10/07/2001 | CA2340936A1 Inhibitors for the formation of soluble human cd23 |
| 10/04/2001 | WO2001073133A1 Compositions and methods for identifying and targeting cancer cells |
| 10/04/2001 | WO2001073132A1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 10/04/2001 | WO2001073131A1 High specificity marker detection |
| 10/04/2001 | WO2001073093A2 Cell-specific adenovirus vectors comprising an internal ribosome entry site |
| 10/04/2001 | WO2001073073A2 Regulation of human neutral protease-related enzyme |
| 10/04/2001 | WO2001073056A2 Regulation of human oxoprolinase-like enzyme |
| 10/04/2001 | WO2001073040A1 Clostridium difficile polypeptides and uses thereof |
| 10/04/2001 | WO2001073034A2 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 10/04/2001 | WO2001073033A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 10/04/2001 | WO2001073032A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 10/04/2001 | WO2001073027A2 Compositions and methods for therapy and diagnosis of colon cancer |
| 10/04/2001 | WO2001073025A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 10/04/2001 | WO2001073020A1 Materials and methods relating to a novel splice variant of a na+ dependent glutamate transporter |
| 10/04/2001 | WO2001073018A2 Human tap-like protein (transporter associated in antigen processing/presentation) |
| 10/04/2001 | WO2001073016A2 Regulation of human tap-related protein |
| 10/04/2001 | WO2001073002A2 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |